Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects

Leukemia

Volumn 12, Issue 12, 1998, Pages 2029-2033

  Hudson, W A ^a   Li, Q ^a   Le, C ^b   Kersey, J H ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Immunosuppression; Leukemia lymphoma; NOD SCID mice; Xenografts

Indexed keywords

ANTIBODY; GANGLIOSIDE GM1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DAUDI CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LEUKEMIA; LYMPHOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAJI CELL; SCID MOUSE; SUBCUTANEOUS TISSUE TUMOR; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR XENOGRAFT; WHOLE BODY RADIATION; XENOTRANSPLANTATION;

EID: 0031730468     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401236     Document Type: Article

References (32)

1. Faguet GB, Agee JF. Transplantation of human hairy cell leukemia in radiation-preconditioned nude mice: characterization of the model by histological, histochemical, phenotypic and tumor kinetic studies. Blood 1988; 71: 1511-1517.
2. McManaway ME, Marti CE, Tosato G, Liu AK, Al-Nasser AA, Kiwanuka J, Magrath IT. Heterotransplantation of human Burkitt's lymphoma cell lines in athymic nude mice: tumor-host relationships. Pathobiology 1993; 61: 164-172.
3. Custer RP, Bosma GC, Bosma MJ. Severe combined immunodeficiency (SCID) in the mouse. Am J Palhol 1985; 120: 464-477.
4. Bosma GC, Davisson MT, Ruetsch NR, Sweet HO, Schultz LD, Bosma MJ. The mouse mutation severe combined immune deficiency (scid) is on chromosome 16. Immunogenetics 1989; 29: 54-57.
5. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527-530.
6. Blase L, Daniel PT, Koretz K, Schwartz-Albiez R, Moller P. The capacity of human malignant B-lymphocytes to disseminate in SCID mice is correlated with functional expression of the fibronectin receptor a5b1 (CD49e/CD29). Int J Cancer 1995; 60: 860-866.
7. Cattan AR, Douglas E. The C.B.17 SCID mouse as a model for human disseminated leukaemia and myeloma in vivo. Leukemia Res 1994; 18: 513-522.
8. Jansen B, Kersey JH, Jaszcz WB, Gunther R, Nguyen DP, Chelstrom LM, Tuel-Ahlgren L, Uckun FM. Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide. Leukemia 1993; 7: 290-297.
9. Chang H, Leeder S, Cook VA, Patterson B, Dosch M, Minden MD, Messner HA. Growth of human lymphoma cells in SCID mice. Lymphoma 1992; 8: 129-136.
10. Jansen B, Vallera DA, Jasczc WB, Nguyen D, Kersey JH. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7. Cancer Res 1992; 52: 1314-1321.
11. Ghetie MA, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES. Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. Int J Cancer 1990; 45: 481-485.
12. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. Rag-1 deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869-877.
13. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180-191.
14. Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody. Cancer Res 1994; 54: 2688-2694.
15. Taghian A, Budach W, Zietman A, Freeman J, Gioioso D, Ruka W, Suit HD. Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice. Cancer Res 1993; 53: 5012-5017.
16. Williams SS, Alosco TR, Croy BA, Bankert RB. The study of human neoplastic disease in severe combined immunodeficient mice. Lab Anim Sci 1993; 43: 139-146.
17. Furukawa T, Kubota T, Watanabe M, Nishibori H, Kuo TH, Saikawa Y, Kase S, Tanino H, Teramoto T, Ishibiki K, Kitajima M. A suitable model for experimental liver metastasis of human colon cancer xenografts using mice with severe combined immunodeficiency. J Surg Oncol 1993; 52: 64-67.
18. Cavacini LA, Giles-Komar J, Kennel M, Quinn A. Effect of immunosuppressive therapy on cytolytic activity of immunodeficient mice: implications for xenogeneic transplantation. Cell Immunol 1992; 144: 296-310.
19. Xie X, Brunner N, Jensen G, Albrectsen J, Gotthardsen B, Rygaard J. Comparative studies between nude and SCID mice on the growth and metastatic behavior of xenografted human tumors. Clin Exp Metastasis 1992; 10: 201-210.
20. Budach W, Hartford A, Gioioso D, Freeman J, Taghian A, Suit HD. Tumors arising in SCID mice share enhanced radiation sensitivity of SCID normal tissues. Cancer Res 1992; 52: 6292-6296.
21. Fulop CM, Phillips RA. The SCID mutation in mice causes a general defect in DNA repair. Nature 1990; 347: 479-482.
22. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 148-154.
23. Glantz SA, Slinker BK. Repeated Measures. In: Day W, Navrozov M (eds). Primer of Applied Regression and Analysis of Variance. McGraw-Hill: New York, 1990, pp 381-463.
24. Garofalo A, Chirivi RGS, Scanziani E, Mayo JG, Vecchi A, Giavazzi R. Comparative study on the metastatic behavior of human tumors in nude, Beige/Nude/Xid and severe combined immunodeficient mice. Invasion Metastasis 1993; 13: 82-91.
25. Terpstra W, Leenen PJM, van den Bos C, Prins A, Loenem WAM, Versiegen MMA, van Wyngaart S, van Rooijen N, Wognum AW, Wagemaker G, Wielengz JJ, Lowenberg B. Facilitated engraftment of human hematopoietic cells in severe combined immunodeficient mice following a single injection of CL2MDP liposomes. Leukemia 1997; 11: 1049-1054.
26. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989; 246: 1597-1600.
27. Zubair AC, Ali SA, Rees RC, Goepel JR, Winfield DA, Goyns MH. Analysis of the colonization of unirradiated and irradiated SCID mice by human lymphoma and non-malignant lymphoid cells. Leuk Lymphoma 1996; 22: 463-471.
28. Huang P, Taghian A, Allam A, Freeman J, Duffy M, Suit HD. The effect of whole-body irradiation of nude mice on the tumor transplantability and control probability of a human soft tissue sarcoma xenograft. Radiat Res 1996; 145: 337-342.
29. Barry TS, Jones DM, Richter CB, Haynes BF. Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens. J Exp Med 1991; 173: 167-180.
30. Sudo K. Improvement of transplantability of human neoplastic cells to nude mice. Jpn J Exp Med 1987; 57: 189-192.
31. Shimizu T, Pelletier H, Hammann A, Olsson NO, Martin MS, Martin F. Effects of a single injection of anti-asialo GM1 serum on natural cytotoxicity and the growth of a regressive colonic tumor in syngeneic rats. Int J Cancer 1987; 40: 676-680.
32. Shpitz B, Chambers CA, Singhal AB, Hozumi N, Fernandes BJ, Roifman CM, Weiner LM, Roder JC, Gallinger S. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Meth 1994; 169: 1-15.